ℹ️
🇬🇧
Search
Search for publications relevant for "AKR1C3"
AKR1C3
Publication
Class
Person
Publication
Programmes
publication
Isoquinoline alkaloids as a novel type of AKR1C3 inhibitors
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Aldo-keto reductase 1C3 (AKR1C3): a missing piece of the puzzle in the dinaciclib interaction profile
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Cloning, expression and purification of AKR1C3
Publication without faculty affiliation
publication
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
Publication without faculty affiliation
publication
Reduction of anticancer drug doxorubicin by recombinant AKR1C3
Publication without faculty affiliation
publication
Role of AKR1C3 in metabolism of anticancer drug oracin
Publication without faculty affiliation
publication
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
2009 |
Central Library of Charles University
publication
AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
2009 |
Faculty of Pharmacy in Hradec Králové
publication
Diet flavonoids inhibit specific aldo-keto reductase AKR1C3
Publication without faculty affiliation
publication
Reduction of anticancer drugs doxorubicin and oracin by recombinant AKR1C3
Publication without faculty affiliation
publication
Olaparib Synergizes the Anticancer Activity of Daunorubicin via Interaction with AKR1C3
2020 |
Faculty of Pharmacy in Hradec Králové
publication
AKR1C3 Inhibitory Potency of Naturally-occurring Amaryllidaceae Alkaloids of Different Structural Types
2017 |
Faculty of Pharmacy in Hradec Králové
publication
Optimization of HPLC technique for measurement of AKR1C3 activity
Publication without faculty affiliation
publication
Bruton's Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib Counteract Anthracycline Resistance in Cancer Cells Expressing AKR1C3
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Inhibition of AKR1C3 human reductase activity by selected flavonoids and NSAID
Publication without faculty affiliation
publication
Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3
2008 |
Central Library of Charles University
publication
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism
2021 |
Faculty of Pharmacy in Hradec Králové
publication
Buparlisib is a novel inhibitor of daunorubicin reduction mediated by aldo-keto reductase 1C3
2019 |
Faculty of Pharmacy in Hradec Králové
publication
Isocitrate dehydrogenase 2 inhibitor enasidenib synergizes daunorubicin cytotoxicity by targeting aldo-keto reductase 1C3 and ATP-binding cassette transporters
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29
2011 |
Faculty of Pharmacy in Hradec Králové
publication
Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells
2008 |
Central Library of Charles University
publication
Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C3
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3
2008 |
Faculty of Pharmacy in Hradec Králové
publication
Interactions of antileukemic drugs with daunorubicin reductases: could reductases affect the clinical efficacy of daunorubicin chemoregimens?
2020 |
Faculty of Pharmacy in Hradec Králové
publication
Bruton's Tyrosine Kinase Inhibitor Zanubrutinib Effectively Modulates Cancer Resistance by Inhibiting Anthracycline Metabolism and Efflux
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters
2019 |
Faculty of Pharmacy in Hradec Králové
publication
In vitro metabolism of fenofibric acid by carbonyl reducing enzymes
2016